Freya Pharma Solutions appoints Christa van Kan as Director Clinical Operations, governing the company’s upcoming confirmatory clinical development program using Lybrido™ against FSIAD
- Wednesday, March 8, 2023, 7:02
- Finance
- Add a comment
AMSTERDAM, March 8, 2023 /PRNewswire/ — Freya Pharma Solutions, a late clinical stage company focusing on the development of effective pharmaceutical therapies for women diagnosed with Female Sexual Disorders (FSD), announced today the appointment of Christa van Kan, MSc (picture below)…
About the Author
adminasapcorp has written 41546 stories on this site.